U.S. Luxury Stock News

Hut 8 Corp. recently agreed to invest about US$16,000,000 to expand West Feliciana Parish’s water system as part of its River Bend AI data center campus, including a new well and roughly eight miles of water main, with the upgraded infrastructure to be handed over to the parish at no cost to taxpayers. This privately funded infrastructure build-out, alongside Hut 8’s large-scale AI data center projects and rising institutional interest, underscores the company’s shift from pure Bitcoin...

Earlier this week, Corcept Therapeutics reported Phase 3 ROSELLA data showing that Lifyorli combined with nab-paclitaxel reduced the risk of death for patients with platinum-resistant ovarian cancer compared with chemotherapy alone, reinforcing the clinical profile of its recently approved therapy. The new overall survival results, presented at ASCO 2026, also support Lifyorli’s inclusion as a preferred regimen in national ovarian cancer treatment guidelines, underscoring its potential...

Why BEAM-302’s latest data matters for Beam Therapeutics stock Beam Therapeutics (BEAM) has drawn fresh attention after presenting updated Phase 1/2 BEAM-302 data for alpha-1 antitrypsin deficiency at the ATS 2026 conference, highlighting safety outcomes, durability signals and reduced neutrophil elastase activity. See our latest analysis for Beam Therapeutics. The updated BEAM-302 data has arrived alongside strong momentum in the stock, with a 7 day share price return of 14.98% and a year to...

Recent performance snapshot Stanley Black & Decker (SWK) has drawn fresh attention after recent share price moves, with the stock near US$79.42 and showing mixed returns over the past week, month, past 3 months, and year to date. See our latest analysis for Stanley Black & Decker. Set against a 1-year total shareholder return of 27.2%, the recent 3.9% 7-day share price return and 4.7% 1-month share price return suggest momentum has picked up again after a softer 90-day patch, even though the...

HealthEquity’s Q1 2027 earnings snapshot HealthEquity (HQY) opened its Q1 2027 report with total revenue of US$354.6 million and basic EPS of US$0.82, supported by net income of US$69.4 million. Over the past six quarters, revenue has moved from US$311.8 million in Q4 2025 to US$354.6 million in Q1 2027, while quarterly basic EPS has ranged from US$0.30 to US$0.82, and trailing twelve month EPS has reached US$2.70 on revenue of about US$1.3 billion. With trailing net profit margins reported...

Why WaFd (WAFD) is on investors’ radar today WaFd (WAFD) has drawn fresh attention after recent share price moves, with the stock last closing at US$35.56. Investors are weighing that level against the bank’s reported revenue and earnings profile. See our latest analysis for WaFd. WaFd’s recent pullback of less than 1% on the day comes after a stronger run, including a 14.12% 90 day share price return and a 29.38% 1 year total shareholder return, suggesting momentum has been building over...

Wondering whether Shake Shack at US$64.31 per share is starting to look like a bargain or still carries too much optimism in the price? This article walks through what that current tag really implies about value. The stock has risen 2.5% over the past week, but is down 36.1% over the last 30 days and has fallen 23.0% year to date and 50.5% over the past year, which can change how investors think about both upside and risk. Recent coverage has focused on how this sharp pullback has reset...

If you are wondering whether Kennametal at around US$32.80 still offers value, the starting point is understanding what the current price already implies about the business. The stock is up 13.1% year to date and 56.7% over the past year, even though it has fallen 9.1% in the last week and 14.9% over the past month. This can change how investors view both its potential and its risks. Recent coverage has focused on how Kennametal fits into broader themes in capital goods and industrial...

In late May 2026, Robinhood Markets launched “Agentic Trading” and an “Agentic Credit Card,” letting customers connect third‑party AI agents to dedicated brokerage and virtual card accounts that can autonomously trade equities and make purchases within user‑defined limits and guardrails. The move effectively brings institutional‑style automated tools, such as portfolio construction, rebalancing and rule‑based strategies via platforms like ChatGPT and Claude, directly to retail investors,...

Lemonade recently reported past first-quarter results showing revenue growth of 70.6% year on year, beating analyst expectations as its AI-driven platform continued expanding across renters, homeowners, pet, auto, and life insurance. Despite this strong top-line performance, the company remains focused on scaling its digital-first insurance model and brand ethos of donating unused premiums, keeping profitability and the long-term effectiveness of its AI underwriting in sharp focus for...

Investors may be considering whether Vertex Pharmaceuticals at around US$447.54 per share is offering good value right now, or if most of the opportunity is already reflected in the price. The stock has been relatively steady recently, with returns of 3.0% over the past week, 4.7% over the past month, a slight decline of 1.0% year to date, and a 1.2% return over the last year, alongside multi year figures of 34.1% over three years and 113.2% over five years. Recent headlines have focused on...

Aveanna Healthcare Holdings Inc. recently repriced its first lien and revolving credit facilities, securing a 50-basis-point cut to interest margins with the potential for a further 25-basis-point reduction if it attains at least a B2 or B credit rating. This refinancing move lowers Aveanna’s financing costs and signals lender confidence in its credit profile, adding incremental flexibility to support its broader home healthcare operations. Next, we examine how this reduction in interest...

Trip.com Group (TCOM) has moved back into focus after its Envision Global Partner Conference, where the company announced new artificial intelligence tools, overseas partnerships, and grant funding aimed at future tourism projects and cross border travel services. See our latest analysis for Trip.com Group. Despite the flurry of new AI tools, partnerships and tourism grants, Trip.com Group’s recent 30 day share price return is down 10.14%, and its year to date share price return is down...

DTE Energy (NYSE:DTE) and LG Energy Solution Vertech plan to deploy eight battery energy storage projects across Michigan. The partnership represents a planned US$1.6b investment in large scale battery infrastructure. The projects are intended to support Michigan’s grid reliability, clean energy goals, and growing data center power needs. DTE Energy (NYSE:DTE) is a regulated utility serving Michigan with electricity and natural gas, so grid reliability and long term capacity planning sit at...

Royal Philips recently announced it has rolled out Disney stories and characters into its Ambient Experience MRI systems across 87 countries, aiming to make pediatric scans less stressful and more engaging for children and their families. This collaboration extends Disney’s large-scale support for children’s healthcare by providing the themed content at no cost, highlighting how the company’s intellectual property can be applied beyond entertainment into real-world care settings. We’ll now...

Shein has accused PDD Holdings’ Temu platform of industrial-scale copyright infringement affecting thousands of product listings. Temu has withdrawn certain legal defenses related to the alleged infringements while simultaneously filing its own counterclaim against Shein. The dispute centers on intellectual property practices in fast fashion e-commerce and is ongoing, with potential implications for Temu’s global operations. PDD Holdings (NasdaqGS:PDD), parent of discount-focused...

T1 Energy (NYSE:TE) is now the focus of the new T-REX 2X Long TE Daily Target ETF, which offers 2x daily long exposure to the stock. The ETF launch introduces a leveraged trading vehicle tied directly to T1 Energy’s share price. This product highlights renewed investor attention as T1 Energy expands its US solar manufacturing footprint. T1 Energy operates in the clean energy space, with an emphasis on solar manufacturing in the US. The introduction of a dedicated 2x daily long ETF reflects...

Why Enphase Energy (ENPH) Is Back on Investors’ Radar Enphase Energy (ENPH) has quietly moved higher recently, with the stock up over the past week, month, and past 3 months. This has prompted investors to reassess what is driving sentiment around the solar technology company. See our latest analysis for Enphase Energy. That recent 30 day share price return of 119.17% and year to date share price return of 102.55% contrast with a 3 year total shareholder return that is down 62.41%. This...

Biogen (BIIB) is in focus after two headline events: a first quarter 2026 earnings beat with steady revenue guidance but lower earnings expectations, and the discontinuation of a Phase 2b Parkinson’s candidate. See our latest analysis for Biogen. At a share price of US$196.0, Biogen’s 1-year total shareholder return of 51.01% contrasts with a 3-year total shareholder return that declined 34.71% and a 5-year total shareholder return that declined 31.50%. This suggests recent momentum has...

Earlier this week, JPMorgan upgraded Allient (NASDAQ: ALNT), a precision motion systems provider in defense, automation, and humanoid robotics, expressing greater confidence in its business outlook. The bank’s view that Allient is well positioned across defense, factory automation, and emerging humanoid robot applications highlights how its motion technologies span both established and developing industrial markets. Next, we’ll examine how JPMorgan’s focus on Allient’s role in humanoid...

Investors may be wondering whether Williams-Sonoma stock still offers value after a strong run, or if most of the opportunity is already priced in. The stock closed at US$203.57, with returns of 5.8% over 7 days, 12.4% over 30 days, 8.4% year to date, 27.7% over 1 year and a very large 3 year return, alongside a 168.8% return over 5 years. This performance can change how the market views its risk and reward profile. Recent coverage has focused on how Williams-Sonoma fits into broader retail...

Viridian Therapeutics has now fully repaid approximately US$55.10 million under its Hercules term loan and entered a long-term commercial manufacturing services agreement under which WuXi Biologics will supply veligrotug for potential commercial use. Together, the debt payoff and manufacturing pact highlight Viridian’s shift toward a less leveraged balance sheet and greater operational readiness for potential product launch. We’ll now examine how Viridian’s full debt repayment shapes its...

This article walks through the key numbers that shape the view on whether Dutch Bros at around US$58 is starting to look expensive, still reasonable, or somewhere in between. The stock has risen about 11.3% over the past week and 4.8% over the past month, even though it is still down 6.7% year to date and 19.7% over the last year, so the recent move may have your attention. Recent company news has focused on Dutch Bros' ongoing store expansion, brand presence and market positioning, which...

Elastic FY 2026 earnings snapshot Elastic (ESTC) has wrapped up FY 2026 with Q4 revenue of US$450.7 million and basic EPS of US$4.18, while trailing twelve month EPS sits at US$3.49 on revenue of US$1.7 billion and net income of US$367.8 million. Over recent quarters, the company has seen revenue range from US$388.4 million in Q4 FY 2025 to US$450.7 million in Q4 FY 2026, with basic EPS moving from a loss of US$0.16 to a profit of US$4.18 as interim periods included both losses and modest...